Abstract
This contribution gives an overview of recent insights and emerging strategies for individualized therapeutic approaches based on genomic and cancer molecular profiles in patients with a morphological diagnosis of renal, bladder and prostate tumors. Significant advances have been made in molecular biology technologies, such as next-generation sequencing and whole-exome sequencing. The rise of such novel techniques has increased our knowledge on tumor cell biology and cancer development, thus allowing us to identify complex genomic abnormalities. These findings have paved the way to provide healthcare from an individual perspective. An emerging strategy to individualize therapeutic interventions is focused on stem cells. Because of their unique characteristics, they are among the most promising candidates as potential vectors carrying suicide genes into different types of cancer, including genitourinary tumors. Another emerging strategy could be based on prostate specific membrane antigen (PSMA), a unique membrane-bound glycoprotein, which is overexpressed manifold in prostate cancer. PSMA can serve as target for delivering therapeutic agents such as cytotoxins or radionuclides.
Keywords: Bladder cancer, beasholer cancer, genito-urinary cancers, kidney cancer, molecular pathology, personalized therapies, prostate cancer, urogenital pathology.
Current Drug Targets
Title:Morphologic and Molecular Backgrounds for Personalized Management of Genito-Urinary Cancers: An Overview
Volume: 16 Issue: 2
Author(s): Rodolfo Montironi, Matteo Santoni, Antonio Lopez-Beltran, Liang Cheng, Holger Moch and Marina Scarpelli
Affiliation:
Keywords: Bladder cancer, beasholer cancer, genito-urinary cancers, kidney cancer, molecular pathology, personalized therapies, prostate cancer, urogenital pathology.
Abstract: This contribution gives an overview of recent insights and emerging strategies for individualized therapeutic approaches based on genomic and cancer molecular profiles in patients with a morphological diagnosis of renal, bladder and prostate tumors. Significant advances have been made in molecular biology technologies, such as next-generation sequencing and whole-exome sequencing. The rise of such novel techniques has increased our knowledge on tumor cell biology and cancer development, thus allowing us to identify complex genomic abnormalities. These findings have paved the way to provide healthcare from an individual perspective. An emerging strategy to individualize therapeutic interventions is focused on stem cells. Because of their unique characteristics, they are among the most promising candidates as potential vectors carrying suicide genes into different types of cancer, including genitourinary tumors. Another emerging strategy could be based on prostate specific membrane antigen (PSMA), a unique membrane-bound glycoprotein, which is overexpressed manifold in prostate cancer. PSMA can serve as target for delivering therapeutic agents such as cytotoxins or radionuclides.
Export Options
About this article
Cite this article as:
Montironi Rodolfo, Santoni Matteo, Lopez-Beltran Antonio, Cheng Liang, Moch Holger and Scarpelli Marina, Morphologic and Molecular Backgrounds for Personalized Management of Genito-Urinary Cancers: An Overview, Current Drug Targets 2015; 16 (2) . https://dx.doi.org/10.2174/1389450115666141202113805
DOI https://dx.doi.org/10.2174/1389450115666141202113805 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PepT1, ASBT-Linked Prodrug Strategy to Improve Oral Bioavailability and Tissue Targeting Distribution
Current Drug Metabolism Biomarker Discovery and Translation in Metabolomics
Current Metabolomics Soft Bipolar Spectrum and Staging in Bipolar Disorder
Current Psychiatry Reviews Transcriptionally Targeted Adenovirus Vectors
Current Gene Therapy Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms
Mini-Reviews in Medicinal Chemistry Comparison of the Inhibitory Effects of Clotrimazole and Ketoconazole against Human Carboxylesterase 2
Current Drug Metabolism Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy One Hundred Faces of Cyclopamine
Current Pharmaceutical Design Magnetic Nanoparticles: Properties, Synthesis and Biomedical Applications
Current Drug Metabolism Mutual Modulation of Femarelle and Vitamin D Analog Activities in Human Derived Female Cultured Osteoblasts
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Recent Advances in Herbal Nanomedicines for Cancer Treatment
Current Molecular Pharmacology Hybrid Pharmacophore Design and Synthesis of Naphthalimide– Benzimidazole Conjugates as Potential Anticancer Agents
Letters in Drug Design & Discovery Nonviral Gene Therapy
Current Gene Therapy Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight
Current Neuropharmacology The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives
Endocrine, Metabolic & Immune Disorders - Drug Targets Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View
Current Cancer Drug Targets Tissue Elastography: Advances in Imaging the Mechanical Properties of Tissue
Recent Patents on Electrical Engineering Bortezomib as an Antitumor Agent
Current Pharmaceutical Biotechnology Double Layered Hydroxides as Potential Anti-Cancer Drug Delivery Agents
Mini-Reviews in Medicinal Chemistry Soy Saponins and the Anticancer Effects of Soybeans and Soy-Based Foods
Current Medicinal Chemistry - Anti-Cancer Agents